61/8006/2026 - Authorization for Exceptional Use of Medication

This tender, referenced 61/8006/2026, relates to the process for obtaining authorization for the exceptional use of a medication. This typically applies when a specific drug is not widely approved or available for a particular indication or patient group, but is deemed necessary due to a lack of alternatives or a specific clinical need. The tender likely outlines the procedures, documentation requirements, and criteria that must be met by healthcare providers or institutions seeking such authorization. It may involve the submission of clinical justifications, evidence of efficacy and safety, and details about the intended patient population. The objective is to establish a formal framework for managing and approving the use of medications under exceptional circumstances, ensuring patient safety and appropriate clinical practice.

This is a supplies contract in the information and communication technology sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 27,123.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.